Cumberland Pharmaceuticals Inc (CPIX): Capital Expenditures
$97.9K
Year ended 2025-12-31
$62.1K
Trailing 12 months to 2026-06-30
-1.4%
3-year compound annual growth
-7.0%
5-year compound annual growth
-3.7%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $97.9K | +47.3% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $66.5K | -76.4% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $281.3K | +175.4% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $102.1K | -1.3% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $103.5K | -26.5% | 2023-03-13, From 2021-01-01 |
| 2020-12-31 | $140.8K | -42.8% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $246.2K | -46.0% | 2022-03-11, From 2019-01-01 |
| 2018-12-31 | $455.6K | +65.1% | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | $276.0K | +110.9% | 2020-03-20, From 2017-01-01 |
| 2016-12-31 | $130.9K | -8.5% | 2019-03-12, From 2016-01-01 |
| 2015-12-31 | $143.0K | -12.4% | 2018-03-09, From 2015-01-01 |
| 2014-12-31 | $163.3K | +67.6% | 2017-03-13, From 2014-01-01 |
| 2013-12-31 | $97.4K | -79.0% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $464.9K | +80.5% | 2015-03-09, From 2012-01-01 |
| 2011-12-31 | $257.5K | -55.4% | 2014-03-11, From 2011-01-01 |
| 2010-12-31 | $577.2K | -4.1% | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | $601.8K | n/a | 2012-03-07, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $97.9K | +47.3% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $562.0K | +253.5% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $518.0K | n/m |
| Septerna, Inc. (SEPN) | 2025-12-31 | $518.0K | -75.4% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $1.59M | +17.3% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $718.0K | -23.5% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $2.0K | -80.0% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $79.0K | n/a |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $0 | -100.0% |
Compare CPIX, AQST, XLO, SEPN side by side · Screen every company in Pharmaceutical Preparations ↗